Stevens-Johnson syndrome induced by methazolamide treatment

Archives of Ophthalmology

Volumn 115, Issue 4, 1997, Pages 550-553

  Shirato, Shiraoki ^a   Kagaya, Fumie ^a   Suzuki, Yasuyuki ^a   Jouhou, Satoru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BETAMETHASONE; CARTEOLOL; METHAZOLAMIDE; METHYLPREDNISOLONE; PILOCARPINE; PREDNISOLONE; TIMOLOL;

ADULT; ARTICLE; BULLOUS SKIN DISEASE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; ERYTHEMA; FEMALE; GLAUCOMA; HLA SYSTEM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RACE; STEVENS JOHNSON SYNDROME; TREATMENT OUTCOME;

EID: 0030902568     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1997.01100150552021     Document Type: Article

References (21)

1. Derick RJ. Carbonic anhydrase inhibitors. In: Mauger TF, Craig EL, eds. Hevener's Ocular Pharmacology. 6th ed. St Louis, Mo: CV Mosby Co; 1994:chap 4.
2. Stevens AM, Johnson FC. A new eruptive fever associated with stomatitis and ophthalmia. AJDC. 1922;24:526-533.
3. Breathnach SM. Drug reactions. In: Champion RH, Bruton JL, Ebling FJG, eds. Textbook of Dermatology. 5th ed. London, England: Blackwell Scientific Publications; 1992:chap 74.
4. Aminlari A. Falling scalp hairs: a side effect of the carbonic anhydrase inhibitor, acetazolamide. Glaucoma. 1984:6:41-42.
5. Weiss IS. Hirsutism after chronic administration of acetazolamide. Am J Ophthalmol. 1974; 78:327-328.
6. Gandham SB, Spaeth GL, Leonardo MD, Costa VP. Methazolamide-induced skin eruptions. Arch Ophthalmol. 1993;111:370-372.
7. Sud RN, Grewal SS. Stevens Johnson syndrome due to Diamox. Indian J Ophthalmol. 1981 ; 29:101-103.
8. Nayak AJ, Rao PNS. Erythema multiforme secondary to acetazolamide (Diamox). Indian J Ophthalmol. 1981:29:105-106.
9. Tanaka M. Methazolamide induced toxic epidermal necrolysis. Rinsho Derma. 1989;43;327330.
10. Totsuka S. Early treatment with topical corticosteroid in Stevens-Johnson syndrome. Rinsho Ganka. 1991 ;45:1001-1005.
11. Nishioka K, Murata M, lhara Y, et al. A case of toxic epidermal necrolysis due to methazolamide. Rinsho Derma. 1994:36:1201-1204.
12. Yamasaki Y, Kobayashi T, Inazumi T. A case of toxic epidermal necrolysis due to methazolamide. Rinsho Derma.\ 994:36:1206-1207.
13. Uchida M, Morikawa M. A case of StevensJohnson syndrome due to methazolamide. Rinsho Derma. 1994;36:1208-1209.
14. Flach AJ, Smith RE, Fraunfelder FT. StevensJohnson syndrome associated with methazolamide treatment reported in two JapaneseAmerican women. Ophthalmology. 1995:102; 1677-1680.
15. Champion RH. Disorders of blood vessels. In: Champion RH, Bruton JL, Ebling FJG, eds. Textbook of Dermatology. 5th ed. London, England: Blackwell Scientific Publications; 1992: chap 41.
16. Yetiv JZ, Bianchine JR, Owen JA. Etiologic factors of the Stevens-Johnson syndrome. South MedJ. 1980:73:599-602.
17. Carrol OM, Bryan PA, Robinson RJ. StevensJohnson syndrome associated with long-acting sulfonamides. JAMA. 1966;195:691-693.
18. Huff JC, Weston WL, Tonnesen MG. Erythema multiforme: critical review of characteristics, diagnostic criteria and causes. J Am Acad Dermatol. 1983:8:763-775.
19. Genvert Gl, Cohen EJ, Donnenfeld ED, Blecher MR Erythema multiforme after use of topical sulfacetamide. Am J Ophthalmol. 1985;99:465-468.
20. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tshuji K, Aizawa M, Sasazuki T, eds. HLA 1991. New York, NY: Oxford University Press Inc; 1991: 1065-1220.
21. Roujeau JC, Huynh TN, Bracq C, Guillaume JC, Revuz J, Touraine R. Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol. 1987;123: 1171-1173.